These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23322571)

  • 21. Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.
    Ma F; Nan K; Lee S; Beadle JR; Hou H; Freeman WR; Hostetler KY; Cheng L
    Eur J Pharm Biopharm; 2015 Jan; 89():271-9. PubMed ID: 25513956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodegradable chitosan and polylactic acid-based intraocular micro-implant for sustained release of methotrexate into vitreous: analysis of pharmacokinetics and toxicity in rabbit eyes.
    Manna S; Banerjee RK; Augsburger JJ; Al-Rjoub MF; Donnell A; Correa ZM
    Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1297-305. PubMed ID: 25896109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular safety of Intravitreal Clindamycin Hydrochloride Released by PLGA Implants.
    Fernandes-Cunha GM; Fialho SL; da Silva GR; Silva-Cunha A; Zhao M; Behar-Cohen F
    Pharm Res; 2017 May; 34(5):1083-1092. PubMed ID: 28224388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxicity and in vivo release profile of sirolimus from implants into the vitreous of rabbits' eyes.
    De Paiva MRB; Lage NA; Guerra MCA; Mol MPG; Ribeiro MCS; Fulgêncio GO; Gomes DA; Da Costa César I; Fialho SL; Silva-Cunha A
    Doc Ophthalmol; 2019 Feb; 138(1):3-19. PubMed ID: 30456454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.
    Kim JS; Beadle JR; Freeman WR; Hostetler KY; Hartmann K; Valiaeva N; Kozak I; Conner L; Trahan J; Aldern KA; Cheng L
    Mol Vis; 2012; 18():1907-17. PubMed ID: 22876115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant.
    Kato A; Kimura H; Okabe K; Okabe J; Kunou N; Ogura Y
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):238-44. PubMed ID: 14691179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous.
    Li J; Lan B; Li X; Sun S; Lu P; Cheng L
    J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noninvasive monitoring of intraocular pharmacokinetics of daunorubicin using fluorophotometry.
    Kizhakkethara I; Li X; el-Sayed S; Khoobehi B; Moshfeghi DM; Rahimy M; Peyman GA
    Int Ophthalmol; 1995-1996; 19(6):363-7. PubMed ID: 8970871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive Monitoring of Choroid-Retina Autofluorescence and Intravitreal Nanoparticle Disposition in Royal College of Surgeon Rats of Different Ages and Retinal Thinning.
    Patil MA; Kompella UB
    J Ocul Pharmacol Ther; 2020; 36(6):458-466. PubMed ID: 32552217
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of bioerodible polymers and daunorubicin in glaucoma filtration surgery.
    Rabowsky JH; Dukes AJ; Lee DA; Leong KW
    Ophthalmology; 1996 May; 103(5):800-7. PubMed ID: 8637691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Toxicity of Intravitreally Injected PLGA Microspheres and Rods in Monkeys and Rabbits: Effects of Depot Size on Inflammatory Response.
    Thackaberry EA; Farman C; Zhong F; Lorget F; Staflin K; Cercillieux A; Miller PE; Schuetz C; Chang D; Famili A; Daugherty AL; Rajagopal K; Bantseev V
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4274-4285. PubMed ID: 28850638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraocular safety and pharmacokinetics of hexadecyloxypropyl-cidofovir (HDP-CDV) as a long-lasting intravitreal antiviral drug.
    Wang H; Chhablani J; Freeman WR; Beadle JR; Hostetler KY; Hartmann K; Conner L; Aldern KA; Pearson L; Cheng L
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9391-6. PubMed ID: 22058340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sustained release of intravitreal flurbiprofen from a novel drug-in-liposome-in-hydrogel formulation.
    Pachis K; Blazaki S; Tzatzarakis M; Klepetsanis P; Naoumidi E; Tsilimbaris M; Antimisiaris SG
    Eur J Pharm Sci; 2017 Nov; 109():324-333. PubMed ID: 28843864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular toxicity of intravitreal clarithromycin.
    Unal M; Peyman GA; Liang C; Hegazy H; Molinari LC; Chen J; Brun S; Tarcha PJ
    Retina; 1999; 19(5):442-6. PubMed ID: 10546942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Self-Assembling Peptide Gel as a Vitreous Substitute: A Rabbit Study.
    Uesugi K; Sakaguchi H; Hayashida Y; Hayashi R; Baba K; Suganuma Y; Yokoi H; Tsujikawa M; Nishida K
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4068-4075. PubMed ID: 28820922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravitreal nanoparticles for retinal delivery.
    Huang X; Chau Y
    Drug Discov Today; 2019 Aug; 24(8):1510-1523. PubMed ID: 31102730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel lipid prodrug strategy for sustained delivery of hexadecyloxypropyl 9-[2-(phosphonomethoxy)ethyl]guanine (HDP-PMEG) on unwanted ocular proliferation.
    Chen M; Hou J; Tan G; Xie P; Freeman WR; Beadle JR; Hostetler KY; Cheng L
    Drug Deliv; 2017 Nov; 24(1):1703-1712. PubMed ID: 29115885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model.
    Chen M; Li X; Liu J; Han Y; Cheng L
    J Control Release; 2015 Apr; 203():109-17. PubMed ID: 25700623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suitability of porous silicon microparticles for the long-term delivery of redox-active therapeutics.
    Wu EC; Andrew JS; Buyanin A; Kinsella JM; Sailor MJ
    Chem Commun (Camb); 2011 May; 47(20):5699-701. PubMed ID: 21503283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New model of proliferative vitreoretinopathy in rabbit for drug delivery and pharmacodynamic studies.
    Moon SW; Sun Y; Warther D; Huffman K; Freeman WR; Sailor MJ; Cheng L
    Drug Deliv; 2018 Jan; 25(1):600-610. PubMed ID: 29461171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.